U.S. Markets closed
  • S&P Futures

    4,283.50
    -3.00 (-0.07%)
     
  • Dow Futures

    33,968.00
    -13.00 (-0.04%)
     
  • Nasdaq Futures

    13,515.00
    -8.25 (-0.06%)
     
  • Russell 2000 Futures

    1,997.80
    -3.90 (-0.19%)
     
  • Crude Oil

    90.17
    -0.33 (-0.36%)
     
  • Gold

    1,769.00
    -2.20 (-0.12%)
     
  • Silver

    19.32
    -0.14 (-0.74%)
     
  • EUR/USD

    1.0084
    -0.0008 (-0.0807%)
     
  • 10-Yr Bond

    2.8800
    -0.0130 (-0.45%)
     
  • Vix

    19.56
    -0.34 (-1.71%)
     
  • GBP/USD

    1.1916
    -0.0017 (-0.1394%)
     
  • USD/JPY

    136.2930
    +0.4310 (+0.3172%)
     
  • BTC-USD

    22,802.30
    -681.54 (-2.90%)
     
  • CMC Crypto 200

    542.20
    -15.53 (-2.78%)
     
  • FTSE 100

    7,541.85
    +26.10 (+0.35%)
     
  • Nikkei 225

    28,967.94
    +25.80 (+0.09%)
     

Where Will CRISPR Therapeutics Be in 1 Year?

·4 min read
Where Will CRISPR Therapeutics Be in 1 Year?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The past year has been challenging for gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP). Clinical-stage biotechs like CRISPR Therapeutics that aren't consistently profitable were hit especially hard. What will the next 12 months have in store for CRISPR Therapeutics?